Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy

Ronald R. Magness, Charles R. Rosenfeld

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Refractoriness to angiotensin-II (ANG II)-induced vasoconstriction is greater in the uteroplacental vs. systemic vascular beds during pregnancy, possibly reflecting enhanced uterine artery prostacyclin production. We determined the role(s) of calcium and calcium channels in regulating basal and ANG II-induced vascular prostacyclin production in uterine and omental (systemic) arteries obtained from pregnant (P) and nonpregnant (NP) ewes. To evaluate the endothelial contribution to basal and stimulated prostacyclin production, arteries with and without endothelium also were incubated in the absence and presence of 50 nM ANG II, 5 μM A23187, or 5 μM arachidonate. Basal prostacyclin production by intact and denuded uterine and systemic arteries was P > NP (P < 0.05), plus in intact arteries, production fell ∼33% in calcium-free Krebs-Henseleit and 5 μM EGTA. Although basal prostacyclin production by P and NP uterine and NP systemic arteries was unaffected by 5 μM verapamil, P systemic artery synthesis fell 41% (P < 0.05). P uterine artery prostacyclin production increased similarly with ANG II (61%) and A23187 (78%) in the presence of calcium (2 mM), whereas NP uterine arteries responded only to A23187 (71%). Verapamil inhibited ANG II-induced increases in prostacyclin synthesis by P uterine arteries. Neither calcium removal nor verapamil altered prostacyclin responses to arachidonate (5 μM). The endothelium accounted for ∼68% of basal prostacyclin production by all arteries studied and for 100% of ANG II-induced increases by P uterine arteries (P < 0.01). A23187 and arachidonate increased both endothelial and smooth muscle prostacyclin production (P < 0.01). During ovine pregnancy, extracellular calcium entry via activation of potential-gated calcium channels are involved in modulating basal vascular prostacyclin production as well as ANG II-induced increases in uterine artery production. Furthermore, the endothelium is the primary source of basal vascular prostacyclin synthesis and the sole source of ANG II-stimulated increases by uterine arteries during pregnancy.

Original languageEnglish (US)
Pages (from-to)2445-2452
Number of pages8
JournalEndocrinology
Volume132
Issue number6
StatePublished - Jun 1993

Fingerprint

Epoprostenol
Endothelium
Uterine Artery
Sheep
Calcium
Angiotensin II
Pregnancy
Arteries
Calcimycin
Blood Vessels
Verapamil
Calcium Channels
Egtazic Acid
Vasoconstriction
Smooth Muscle

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy. / Magness, Ronald R.; Rosenfeld, Charles R.

In: Endocrinology, Vol. 132, No. 6, 06.1993, p. 2445-2452.

Research output: Contribution to journalArticle

@article{151dc38e4b344bfc81d9827051e3f523,
title = "Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy",
abstract = "Refractoriness to angiotensin-II (ANG II)-induced vasoconstriction is greater in the uteroplacental vs. systemic vascular beds during pregnancy, possibly reflecting enhanced uterine artery prostacyclin production. We determined the role(s) of calcium and calcium channels in regulating basal and ANG II-induced vascular prostacyclin production in uterine and omental (systemic) arteries obtained from pregnant (P) and nonpregnant (NP) ewes. To evaluate the endothelial contribution to basal and stimulated prostacyclin production, arteries with and without endothelium also were incubated in the absence and presence of 50 nM ANG II, 5 μM A23187, or 5 μM arachidonate. Basal prostacyclin production by intact and denuded uterine and systemic arteries was P > NP (P < 0.05), plus in intact arteries, production fell ∼33{\%} in calcium-free Krebs-Henseleit and 5 μM EGTA. Although basal prostacyclin production by P and NP uterine and NP systemic arteries was unaffected by 5 μM verapamil, P systemic artery synthesis fell 41{\%} (P < 0.05). P uterine artery prostacyclin production increased similarly with ANG II (61{\%}) and A23187 (78{\%}) in the presence of calcium (2 mM), whereas NP uterine arteries responded only to A23187 (71{\%}). Verapamil inhibited ANG II-induced increases in prostacyclin synthesis by P uterine arteries. Neither calcium removal nor verapamil altered prostacyclin responses to arachidonate (5 μM). The endothelium accounted for ∼68{\%} of basal prostacyclin production by all arteries studied and for 100{\%} of ANG II-induced increases by P uterine arteries (P < 0.01). A23187 and arachidonate increased both endothelial and smooth muscle prostacyclin production (P < 0.01). During ovine pregnancy, extracellular calcium entry via activation of potential-gated calcium channels are involved in modulating basal vascular prostacyclin production as well as ANG II-induced increases in uterine artery production. Furthermore, the endothelium is the primary source of basal vascular prostacyclin synthesis and the sole source of ANG II-stimulated increases by uterine arteries during pregnancy.",
author = "Magness, {Ronald R.} and Rosenfeld, {Charles R.}",
year = "1993",
month = "6",
language = "English (US)",
volume = "132",
pages = "2445--2452",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Calcium modulation of endothelium-derived prostacyclin production in ovine pregnancy

AU - Magness, Ronald R.

AU - Rosenfeld, Charles R.

PY - 1993/6

Y1 - 1993/6

N2 - Refractoriness to angiotensin-II (ANG II)-induced vasoconstriction is greater in the uteroplacental vs. systemic vascular beds during pregnancy, possibly reflecting enhanced uterine artery prostacyclin production. We determined the role(s) of calcium and calcium channels in regulating basal and ANG II-induced vascular prostacyclin production in uterine and omental (systemic) arteries obtained from pregnant (P) and nonpregnant (NP) ewes. To evaluate the endothelial contribution to basal and stimulated prostacyclin production, arteries with and without endothelium also were incubated in the absence and presence of 50 nM ANG II, 5 μM A23187, or 5 μM arachidonate. Basal prostacyclin production by intact and denuded uterine and systemic arteries was P > NP (P < 0.05), plus in intact arteries, production fell ∼33% in calcium-free Krebs-Henseleit and 5 μM EGTA. Although basal prostacyclin production by P and NP uterine and NP systemic arteries was unaffected by 5 μM verapamil, P systemic artery synthesis fell 41% (P < 0.05). P uterine artery prostacyclin production increased similarly with ANG II (61%) and A23187 (78%) in the presence of calcium (2 mM), whereas NP uterine arteries responded only to A23187 (71%). Verapamil inhibited ANG II-induced increases in prostacyclin synthesis by P uterine arteries. Neither calcium removal nor verapamil altered prostacyclin responses to arachidonate (5 μM). The endothelium accounted for ∼68% of basal prostacyclin production by all arteries studied and for 100% of ANG II-induced increases by P uterine arteries (P < 0.01). A23187 and arachidonate increased both endothelial and smooth muscle prostacyclin production (P < 0.01). During ovine pregnancy, extracellular calcium entry via activation of potential-gated calcium channels are involved in modulating basal vascular prostacyclin production as well as ANG II-induced increases in uterine artery production. Furthermore, the endothelium is the primary source of basal vascular prostacyclin synthesis and the sole source of ANG II-stimulated increases by uterine arteries during pregnancy.

AB - Refractoriness to angiotensin-II (ANG II)-induced vasoconstriction is greater in the uteroplacental vs. systemic vascular beds during pregnancy, possibly reflecting enhanced uterine artery prostacyclin production. We determined the role(s) of calcium and calcium channels in regulating basal and ANG II-induced vascular prostacyclin production in uterine and omental (systemic) arteries obtained from pregnant (P) and nonpregnant (NP) ewes. To evaluate the endothelial contribution to basal and stimulated prostacyclin production, arteries with and without endothelium also were incubated in the absence and presence of 50 nM ANG II, 5 μM A23187, or 5 μM arachidonate. Basal prostacyclin production by intact and denuded uterine and systemic arteries was P > NP (P < 0.05), plus in intact arteries, production fell ∼33% in calcium-free Krebs-Henseleit and 5 μM EGTA. Although basal prostacyclin production by P and NP uterine and NP systemic arteries was unaffected by 5 μM verapamil, P systemic artery synthesis fell 41% (P < 0.05). P uterine artery prostacyclin production increased similarly with ANG II (61%) and A23187 (78%) in the presence of calcium (2 mM), whereas NP uterine arteries responded only to A23187 (71%). Verapamil inhibited ANG II-induced increases in prostacyclin synthesis by P uterine arteries. Neither calcium removal nor verapamil altered prostacyclin responses to arachidonate (5 μM). The endothelium accounted for ∼68% of basal prostacyclin production by all arteries studied and for 100% of ANG II-induced increases by P uterine arteries (P < 0.01). A23187 and arachidonate increased both endothelial and smooth muscle prostacyclin production (P < 0.01). During ovine pregnancy, extracellular calcium entry via activation of potential-gated calcium channels are involved in modulating basal vascular prostacyclin production as well as ANG II-induced increases in uterine artery production. Furthermore, the endothelium is the primary source of basal vascular prostacyclin synthesis and the sole source of ANG II-stimulated increases by uterine arteries during pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0027190655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027190655&partnerID=8YFLogxK

M3 - Article

C2 - 8389281

AN - SCOPUS:0027190655

VL - 132

SP - 2445

EP - 2452

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -